Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Torres

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Annals of the American Thoracic Society|April 15, 2016
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center ExperienceCatherine H Miele, Kristin Schwab, Rajeev Saggar, et al.
Journal of Clinical Medicine|October 1, 2020
Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19Enrique Rodilla, Alberto Saura, Iratxe Jiménez, et al.
Scientific Reports|March 5, 2025
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 RegistryCrhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Lucía Barrera-López, et al.
Anesthesiology|February 6, 2020
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac SurgeryDaniel I Sessler, David Conen, Kate Leslie, et al.
BMC Medicine|November 16, 2020
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort studyLuis M Pérez-Belmonte, José David Torres-Peña, María D López-Carmona, et al.
Drugs|March 30, 2021
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 RegistryJosé David Torres-Peña, Luis M Pérez-Belmonte, Francisco Fuentes-Jiménez, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Journal of Clinical Medicine|July 2, 2021
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, et al.
Annals of Medicine|October 16, 2020
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 RegistryFrancisco Javier Carrasco-Sánchez, Mª Dolores López-Carmona, Francisco Javier Martínez-Marcos, et al.
Journal of Clinical Medicine|April 12, 2022
Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 RegistryJose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, Almudena López-Sampalo, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Annals of the American Thoracic Society|April 15, 2016
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center ExperienceCatherine H Miele, Kristin Schwab, Rajeev Saggar, et al.
Journal of Clinical Medicine|October 1, 2020
Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19Enrique Rodilla, Alberto Saura, Iratxe Jiménez, et al.
Scientific Reports|March 5, 2025
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 RegistryCrhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Lucía Barrera-López, et al.
Anesthesiology|February 6, 2020
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac SurgeryDaniel I Sessler, David Conen, Kate Leslie, et al.
BMC Medicine|November 16, 2020
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort studyLuis M Pérez-Belmonte, José David Torres-Peña, María D López-Carmona, et al.
Drugs|March 30, 2021
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 RegistryJosé David Torres-Peña, Luis M Pérez-Belmonte, Francisco Fuentes-Jiménez, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Journal of Clinical Medicine|July 2, 2021
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, et al.
Annals of Medicine|October 16, 2020
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 RegistryFrancisco Javier Carrasco-Sánchez, Mª Dolores López-Carmona, Francisco Javier Martínez-Marcos, et al.
Journal of Clinical Medicine|April 12, 2022
Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 RegistryJose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, Almudena López-Sampalo, et al.
Pageof 16